Next Article in Journal
Molecular Insights and Novel Therapies for Lymphoproliferative Disorders
Previous Article in Journal
Fungal Cordyceps Nucleosides and Analogs as Potential Anti-Glioblastoma PD-L1 Inhibitors: An In Silico Multiparameter Optimization (MPO) Design
Previous Article in Special Issue
Reversal of Chloroquine Resistance in Plasmodium falciparum in Gabon: A Phenotype-Genotype Relationship over the Last 20 Years
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Long Non-Coding RNAs Identified as Hub Genes by Weighted Gene Co-Expression Network Analysis in Schistosoma mansoni Following Incubation with Bothrops Snake Venoms

by
Marina Zenga-Carrenho
1,†,
Agatha Fischer-Carvalho
1,†,
Tereza Cristina Taveira-Barbosa
1,
Pedro Jardim Poli
1,
Vilaça Guimarães-Oliveira
1,2,
Alison Felipe Alencar Chaves
3,
Solange M. T. Serrano
3,
Ana Carolina Tahira
1,
Sergio Verjovski-Almeida
1,4 and
Murilo Sena Amaral
1,*
1
Laboratório de Ciclo Celular, Instituto Butantan, São Paulo 05503-900, SP, Brazil
2
Programa de Pós-Graduação Interunidades em Biotecnologia, Universidade de São Paulo, São Paulo 05508-000, SP, Brazil
3
Laboratório de Toxinologia Aplicada, Center of Toxins, Immune-Response, and Cell Signaling (CeTICS), Butantan Institute, São Paulo 05503-900, SP, Brazil
4
Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, SP, Brazil
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2026, 27(11), 5027; https://doi.org/10.3390/ijms27115027
Submission received: 13 April 2026 / Revised: 23 May 2026 / Accepted: 29 May 2026 / Published: 2 June 2026
(This article belongs to the Special Issue Molecular Research on Parasitic Infection)

Abstract

Emerging tolerance of Schistosoma mansoni to praziquantel, the only drug available for schistosomiasis treatment, highlights the need for new therapeutic targets. Snake venoms contain pharmacologically active proteins and peptides that can decrease the viability of S. mansoni worms in vitro. Long non-coding RNAs (lncRNAs) play important roles in S. mansoni and are promising new therapeutic targets. However, new candidates still need to be identified, as only four S. mansoni lncRNAs have been functionally characterized to date. Therefore, we investigated lncRNA expression changes in S. mansoni following incubation with Bothrops venoms. Adult worms were incubated with eight venoms at a sublethal dose, and phenotypic parameters were evaluated. RNA-Seq was conducted on worms incubated with Bothrops jararacussu or Bothrops moojeni venoms, followed by Weighted Gene Co-expression Network Analysis for each sex. B. moojeni venom reduced all phenotypic measurements, while B. jararacussu reduced oviposition. Both venoms altered global gene expression, including lncRNAs. Females showed two lncRNA hub genes in two venom-associated co-expression modules, while males showed 61 lncRNA hub genes in nine venom-associated modules. RT-qPCR validated six out of seven selected hub lncRNAs in male worms. These results reveal the involvement of lncRNAs in S. mansoni gene expression modulation induced by Bothrops venoms and point to lncRNAs that should be prioritized in future functional studies, such as SmLINC121220-IBu, SmLINC152105-IBu and SmLNCA123831-IBu.

1. Introduction

Schistosomiasis is a neglected disease caused by trematodes of the genus Schistosoma, with 240 million people requiring preventive chemotherapy and about 700 million people living in at-risk areas [1,2]. The disease has two main forms: urogenital schistosomiasis, caused by Schistosoma haematobium, and intestinal schistosomiasis, mainly caused by Schistosoma japonicum and Schistosoma mansoni [3]. Praziquantel (PZQ) is the only drug currently indicated for the treatment of schistosomiasis. However, there are reports of parasite tolerance to the drug [4]. In addition, PZQ is not effective against immature forms of the parasite (schistosomula) [5,6]. Therefore, the search for new pharmacological targets and novel antischistosomal compounds is necessary.
Currently, most candidate compounds are plant-derived, which have been extensively studied for their antischistosomal properties [7]. In contrast, animal-derived compounds have received comparatively less attention, as reviewed by our group in [8], despite being a major focus of drug discovery for various other therapeutic applications [9,10]. To date, few studies have reported the antischistosomal activity of animal natural products, although with promising results [11,12,13,14,15,16,17,18]. In this context, snakes of the genus Bothrops are of major medical importance in Central and South America, as they are responsible for the highest rates of envenomation in the region [19]. Bothrops snake venoms have complex composition, being rich in components with pharmacological and biotechnological potential, such as metalloproteases and serine proteases, phospholipases A2, L-amino acid oxidases, 5′-nucleotidases, hyaluronidase, and C-type lectins [20,21], which disrupt multiple molecular targets in the victim. Bites from Bothrops snakes trigger intense local reactions, typically involving severe pain, inflammation, blistering, and tissue necrosis. Beyond the bite site, the venom’s systemic impact can cause low blood pressure, blood clotting disturbance, and bleeding gums. In the most critical instances, this can escalate to circulatory collapse and kidney failure [22,23].
Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides with low or no protein-coding potential [24,25,26], proposed to be used in new therapeutic strategies against several diseases [27,28]. In mammals, lncRNAs are known to play numerous roles in organism homeostasis, such as gene regulation and drug resistance [29,30,31,32]. In S. mansoni, lncRNAs were first described in 2011 [33] and have since been identified across different parasite life-cycle stages [34,35,36,37,38]. Recently, lncRNAs were shown to be essential for S. mansoni adult worm homeostasis, survival and fertility [39,40] and, therefore, proposed as putative new therapeutic targets against schistosomiasis [40]. LncRNAs were also shown to be sensitive to stress in S. mansoni, with their expression levels modulated by drugs such as PZQ in vivo [41] and the ribonucleoside analog 5-azacytidine (5-AzaC) in vitro [42]. Since only four out of thousands of lncRNAs have been silenced and functionally evaluated in S. mansoni so far [39,40], new candidate lncRNAs still need to be identified.
Thus, this study aimed to identify lncRNA expression patterns in S. mansoni adult worms under stress induced by incubation with Bothrops snake venoms. In addition to pointing to the molecular mechanisms by which Bothrops venoms induce parasite death and potential target genes, this work aimed to open new perspectives through a broader evaluation of S. mansoni gene expression following venom incubation using RNA-Seq and Weighted Gene Co-expression Network Analysis (WGCNA). Thus, by identifying a set of S. mansoni genes affected by Bothrops venoms, this study indicates lncRNAs that should be prioritized in future functional studies focusing on the development of new lncRNA-based therapeutic alternatives against schistosomiasis.

2. Results

2.1. Bothrops moojeni In Vitro Incubation Reduces Pairing, Adhesion, Motility, Viability, and Oviposition of Schistosoma mansoni Adult Worms

To assess possible differential expression of lncRNAs upon incubation of S. mansoni adult couples with Bothrops venoms, we first screened the antischistosomal potential of eight venoms obtained from the snakes Bothrops atrox, Bothrops brazili, Bothrops cotiara, Bothrops jararaca, Bothrops jararacussu, Bothrops leucurus, Bothrops moojeni, and Bothrops neuwiedi using a sublethal dose (25 µg/mL) to select venoms for further RNA-Seq experiments. Only the venom of B. moojeni significantly reduced pairing of adult worms, with only 18.9% remaining paired following exposure to venom (Figure 1A). Regarding attachment to the plate, venoms from B. moojeni and B. leucurus led to a significant reduction in worm attachment to 8.9% and 47.7%, respectively (Figure 1B). Concerning motility and viability, only the B. moojeni venom caused a significant decrease to 26% and 52% in the relative motility index and ATP levels of adult worms, respectively (Figure 1C,D). All eight venoms tested significantly reduced oviposition (Figure 1E), with B. moojeni venom causing almost complete inhibition of oviposition. Considering that the B. moojeni venom was the only one that reduced all phenotypic features measured, and that the B. jararacussu venom reduced oviposition and is a venom well known for its richness in molecules with pharmacological potential [43,44,45,46], we performed RNA-Seq with adult samples incubated with either B. moojeni or B. jararacussu venom. Supplementary Table S1 shows the list of all S. mansoni transcripts detected in the RNA-Seq, along with their TPM (transcripts per million) values.

2.2. S. mansoni Males Show a Higher Number of Differentially Expressed (DE) Genes than Females in the RNA-Seq

Incubation of S. mansoni adult worm couples with a sublethal dose (25 µg/mL) of both B. jararacussu or B. moojeni venoms significantly changed the global profile of gene expression in males. RNA-Seq analysis showed that males incubated with B. jararacussu venom had 2117 significantly (FDR ≤ 5%) differentially expressed genes (DEGs) (Figure 2A), while males incubated with B. moojeni showed the highest number of significantly (FDR ≤ 5%) DEGs, 4804, compared with the controls (Figure 2B).
Meanwhile, females exposed to the same concentration (25 µg/mL) of either of the two venoms showed a considerably lower number of significantly (FDR ≤ 5%) DEGs compared with males. To account for the pronounced sexual distinction in the gene expression response, we applied a more permissive threshold for females (FDR ≤ 10%) compared with the FDR used for males; of note, at a strict FDR ≤ 5%, females yielded insufficient DEGs (0 to 116) for downstream analyses, unlike the much more robust response observed in males. Thus, a total of 127 significantly (FDR ≤ 10%) DEGs were detected (Figure 3A) following females’ exposure to B. jararacussu venom, while exposure to B. moojeni venom led to 679 significantly (FDR ≤ 10%) DEGs (Figure 3B), when compared with the respective controls. Lists of all significantly DE protein-coding genes and lncRNAs from Figure 2 and Figure 3 are given in Supplementary Tables S2–S5.
In addition, when comparing the overlap of DEGs between parasites exposed to either B. moojeni or B. jararacussu venoms, 86% of DEGs affected in males by B. jararacussu venom are also detected as DEGs under incubation of males with B. moojeni venom (Figure 4A,B). Similarly, in females, 78% of DEGs affected by B. jararacussu venom are also DEGs following B. moojeni venom incubation (Figure 4C,D). These findings suggest that within each sex, the two venoms affect similar pathways on the parasites; nevertheless, B. moojeni venom affects a considerably larger number of genes in both sexes than B. jararacussu venom.

2.3. LncRNAs Are Differentially Expressed (DE) in S. mansoni Males and Females Incubated with B. jararacussu or B. moojeni Venoms

Among the DEGs detected in male or female worms exposed to both venoms, there was a relevant proportion of significantly DE lncRNAs. Except for females incubated with B. jararacussu, in which 6% of the total DEGs were lncRNA genes, approximately 9–10% of the total DEGs of all other treatment groups were lncRNAs (Supplementary Table S6). Of interest, most of the significantly DE lncRNAs are long intergenic non-coding RNAs (lincRNAs, 62.5% to 71.6% of total DE lncRNAs), followed by long antisense non-coding RNAs (lncaRNAs, 26.9% to 37.5% of total DE lncRNAs), and long sense non-coding RNAs (lncsRNAs, 0% to 4.4% of total DE lncRNAs) (Supplementary Tables S2–S5).

2.4. S. mansoni Males Show More lncRNAs Hubs of Modules Significantly Associated with Venom Incubation than Females

Next, we used WGCNA to look for co-expression between lncRNAs and protein-coding genes, attempting to infer which functional pathways in the parasites were significantly affected by the genome-wide expression reprogramming induced by venom exposure, and which functional roles the lincRNAs may have. In the WGCNA of female samples exposed to B. jararacussu or B. moojeni venoms, a total of 49 co-expression modules were identified, with an average of 353 genes per module. The largest module was turquoise, containing 1506 transcripts, whereas the smallest module was plum2, containing 150 transcripts. Among the identified modules, nine of them showed a statistically significant association with treatment with one or both venoms (p-value < 0.05), and these modules, along with modules comprising DE lncRNAs, are shown in Supplementary Table S7. Furthermore, in females, exposure to B. moojeni venom had a greater impact on gene expression than exposure to B. jararacussu venom, both in terms of the number of DEGs identified and in their significant association with modules in each analysis (Supplementary Table S7).
To identify the modules that were significantly associated with specific biological functions in females, we performed a clusterProfiler analysis and found that 15 modules showed significantly enriched Gene Ontology (GO) terms across the three GO categories, namely Biological Process (BP), Cellular Component (CC), and Molecular Function (MF) (Figure 5 and Supplementary Table S8). The darkslateblue module presented the highest number of significantly enriched GO terms, totaling 138, with 131 GO terms in the BP category and 7 in the MF category; the top five enriched GO terms in the BP category are oocyte maturation, ruffle assembly, cell chemotaxis, heat generation and fever generation.
Moreover, 105 transcripts were identified as both hub genes and DEGs in at least one of the venom treatments in female samples. Of these, 25 transcripts were hubs and DEGs in the B. jararacussu treatment across five modules, and 103 transcripts were hubs and DEGs in the B. moojeni treatment across 19 modules, with the brown module containing the highest number of hub DEGs. Since it was possible to design RT-qPCR primers for only one DE lncRNA hub out of the two present in these modules, we did not proceed to RT-qPCR validation of any target in female samples.
Interestingly, in the WGCNA of male parasite samples exposed to B. jararacussu or B. moojeni venoms, a total of 21 modules were identified, each one containing an average of 790 genes. The largest module was turquoise, containing 4288 transcripts, whereas the smallest module was dark red, containing 223 transcripts. Among the identified modules, ten of them showed a significant association with one or both venom treatments (p-value < 0.05) (Supplementary Table S9). In males, as in females, exposure to B. moojeni venom had a greater impact on gene expression than exposure to B. jararacussu venom, both in terms of the number of DEGs identified and their significant association with modules in each analysis (Supplementary Table S9).
In the B. jararacussu treatment, five modules were significantly associated with the venom exposure: one positively associated (turquoise) and four negatively associated (green, greenyellow, red, and royalblue). In three of these modules (green, red, and turquoise), the enrichment with DEGs is significantly associated with the modules (Supplementary Table S9). In contrast, in the B. moojeni treatment, eight modules were significantly associated with the venom exposure: four positively associated and four negatively associated (Supplementary Table S9). In all these modules, except for brown and light yellow, the enrichment with DEGs is significantly associated with the modules. The turquoise module was enriched with the highest number of DEGs in both venom incubations: 1326 out of 2147 in the B. jararacussu treatment, and 1960 out of 5662 in the B. moojeni treatment (Supplementary Table S9). In the clusterProfiler analysis across the three GO categories (BP, CC, and MF) to identify modules significantly associated with specific biological functions, 11 modules presented enriched GO terms, with the brown module showing the highest number of significantly enriched GO terms (339) (Supplementary Table S10).
Furthermore, 1031 transcripts were identified as both hub genes and DEGs in at least one of the venom treatments. Of these, 519 transcripts were hubs and DEGs in the B. jararacussu treatment across 10 modules, and 985 transcripts were hubs and DEGs in the B. moojeni treatment across 11 modules. Based on this analysis, we selected and were able to design efficient primer pairs for RT-qPCR validation for seven DE hub lncRNAs in S. mansoni males: five lincRNAs (SmLINC115582-IBu, SmLINC116522-IBu, SmLINC121220-IBu, SmLINC150454-IBu and SmLINC152105-IBu), one lncaRNA (SmLNCA123831-IBu) and one lncsRNA (SmLNCS129871-IBu).
Four of these selected hub lncRNAs (SmLINC116522-IBu, SmLINC121220-IBu, SmLINC152105-IBu and SmLNCA123831-IBu) belong to the turquoise module, while two belong to the green module (SmLINC115582-IBu and SmLNCS129871-IBu) and one (SmLINC150454-IBu) to the blue module (Supplementary Table S11). Blue module has no GO term enrichment, while the green module is enriched with MF GO terms related to isomerase activity, racemase and epimerase activity, and turquoise is enriched with the CC GO term related to postsynaptic membrane (Figure 6). Modules blue, green and turquoise co-expression networks are shown in Figure 7. While the blue module showed no significant GO enrichment (Figure 7A), the green module displayed enriched GO terms and two hub lncRNAs (SmLINC115582-IBu and SmLNCS129871-IBu) (Figure 7B). Notably, the turquoise module presented one enriched GO term (postsynaptic membrane) connected to three of the selected differentially expressed lncRNAs (Figure 7C), suggesting potential functional associations within this module.

2.5. Six lncRNA Hubs Were Validated by RT-qPCR in S. mansoni Male Samples Incubated with B. jararacussu or B. moojeni Venoms

Overall, the gene expression of the DE lncRNAs evaluated by RT-qPCR presented a similar pattern as that in the RNA-Seq analyses, with correlation coefficients higher than 0.84 (Supplementary Figure S1). In the RT-qPCR, parasites incubated with B. moojeni venom showed, as in the RNA-Seq, significantly higher expression of SmLINC116522-IBu, SmLINC121220-IBu, SmLINC150454-IBu, SmLINC152105-IBu and SmLNCS129871-IBu, and significantly lower expression of SmLNCA123831-IBu when compared with control samples (Figure 8). Meanwhile, male parasites incubated with B. jararacussu venom showed significantly higher expression of SmLINC121220-IBu and lower expression of SmLNCA123831-IBu compared with control samples (Figure 8).
We also selected, as a control, a lncRNA (SmLINC143821-IBu) that is not DE in male samples incubated with neither of the venoms. In the RT-qPCR, SmLINC143821-IBu showed a similar gene expression between control and incubated samples as in the RNA-Seq (Supplementary Figure S2). Thus, six DE hub-lncRNAs (SmLINC116522-IBu, SmLINC121220-IBu, SmLINC150454-IBu, SmLINC152105-IBu, SmLNCA123831-IBu and SmLNCS129871-IBu) and one non-DE lncRNA (SmLINC143821-IBu) had RNA-Seq results validated by RT-qPCR in samples of S. mansoni males incubated with Bothrops venoms.

3. Discussion

In this study, we showed that Bothrops snake venoms, such as B. jararacussu or B. moojeni, can phenotypically affect S. mansoni worms following in vitro incubation for 24 h with a sublethal dose of 25 µg/mL. Incubation with B. moojeni venom significantly reduced parasite pairing, adhesion, motility, viability, and oviposition, representing a suitable candidate for further studies aiming at investigating and isolating the venom molecules responsible for these observed effects. The phenotypical results are consistent with previous reports of in vivo and in vitro treatment targeting S. mansoni with Cerastes cerastes venom and in vivo administration of MjTX-II, a phospholipase A2 homolog obtained from B. moojeni, which led to reduced viability and oviposition, along with other phenotypical results [12,14,18]. Together with these previous findings, our results emphasize the little explored potential of snake venoms as a source of pharmacologically active molecules against parasites such as S. mansoni [8].
In addition to the phenotypical effects, incubation with B. jararacussu or B. moojeni venoms also led to molecular changes in both male and female S. mansoni worms. Male worms showed a higher number of DEGs than females after incubation with each of the venoms, showing that the gene expression effects of exposure to Bothrops venoms are higher in male than female worms. It has been shown that male S. mansoni are phenotypically more susceptible to in vitro incubation with some compounds, including PZQ [5], ginger (Zinziber officinale) extract [47], some alkylated diamines and amino alcohols [48], essential oil of Ageratum conyzoides [49], and C. cerastes venom [14]. Still, female worms are more susceptible to in vitro incubation with artesunate [50] and anti-malarial drugs [51], while there is no differential sensitivity between sexes upon incubation with (+)-Limonene Epoxide [52], Plectranthus neochilus [53] and Piper cubeba [49] essential oils. Thus, these differences in susceptibility between male and female S. mansoni may be associated with intrinsic sex-specific characteristics that lead to different levels of sensitivity depending on the mechanism of action of the compound.
The precise mechanisms of action of the venoms in schistosomes are unknown; considering the higher sensitivity of males to venom incubation, it is possible that these mechanisms may involve direct effects on the tegument and, consequently, the activation of surface receptors. This direct effect could explain the more pronounced molecular changes observed in males, as they have a larger contact surface with the environment than females. Meanwhile, male and female worms differ in their tegumental composition regarding molecules such as proteins, lipids and N-glycans [54,55,56]. Specifically, male lipid tegumental composition, with higher fatty acyl substituents and a higher number of double bonds compared with females, leads to a higher fluidity in male tegument compared with females [55]. Considering that Bothrops snake venom composition includes enzymes such as metalloproteases, serine proteases, and phospholipases [20,21], the difference in tegumental fluidity and composition regarding proteins, lipids and N-glycans may lead to a higher male sensitivity to the venoms. Furthermore, in adult S. mansoni worms, there is a larger number of male-biased than female-biased genes, i.e., there are more genes with significantly higher expression in males than in females [57]. In this context, male worms could show an enhanced gene expression regulation after exposure to B. jararacussu or B. moojeni venoms due to their higher sensitivity to the venom mechanism of action and/or because of their higher transcriptional plasticity, caused by male-biased genes, in response to stressful conditions.
In addition, enriched GO terms in male modules significantly associated with one or both venom incubation conditions (Supplementary Table S12) point to a systemic collapse involving basic cellular machinery (“cytoplasmic translation”; “nuclear division”; “chromosome segregation”), profound epigenetic reprogramming (“histone binding”; “methylated histone binding”; “chromatin binding”), and involvement of neuromuscular function and electrolyte balance (“postsynaptic membrane”; “voltage-gated potassium channel complex”; “ion channel complex”). In contrast, enriched GO terms in female modules significantly associated with venom incubation (Supplementary Table S13) indicate a more structural and restricted response, involving regulation of genes related to surface integrity (“extracellular matrix”; “integral component of plasma membrane”; “collagen-containing extracellular matrix”) and reproduction (“female germline ring canal”; “female germline ring canal inner rim”). Ultimately, this difference in molecular responses may reveal a more tightly regulated gene expression program in females, which is more resistant to venom-induced reprogramming than in males. These data suggest a molecular basis for the sex-specific susceptibility to venom, demonstrating a pervasive systemic collapse in the male compared with the more targeted structural response in the female.
In this study, 6–10% of the genes significantly DE upon incubation with either of the two venoms in male and female worms are lncRNAs. LncRNAs play essential roles in eukaryotes’ gene regulation [29,30] and are associated with drug resistance mechanisms [31], presenting a strong potential as therapeutic targets against parasites, including schistosomes [39,40,58]. In S. mansoni, lncRNAs are known to be essential for worm homeostasis and reproduction [39]. They are modulated upon parasite drug exposure to drugs, such as in the in vivo treatment with PZQ [41], the only currently indicated treatment for schistosomiasis, or in the in vitro incubation with 5-AzaC, an epigenetic drug [42]. Thus, investigating lncRNAs affected by Bothrops snake venom incubation may help to identify lncRNAs that are modulated in the parasites under stress, which can be tested in the future as putative pharmacological alternatives against schistosomiasis.
To date, only four lncRNAs have been functionally evaluated and silenced in S. mansoni [39,40]. SmLINC156349-IBu knockdown decreased S. mansoni viability and oviposition, and impaired parasite pairing, adhesion, and motility [40]. Meanwhile, SmLINC101519-IBu, SmLINC110998-IBu and SmLINC175062-IBu knockdown reduced parasite pairing, adhesion, motility and/or oviposition, while SmLINC101519-IBu silencing reduced worms’ viability [39]. These results show the role of lncRNAs in S. mansoni homeostasis and reproduction and highlight the potential of these RNAs as therapeutic targets while also emphasizing how much is yet to be discovered about lncRNAs in S. mansoni. While most of these previously studied lncRNAs are not DE in the context of this study, SmLINC101519-IBu is significantly DE in males incubated with B. moojeni, and some of them are part of modules significantly associated with venom incubation obtained in the WGCNA. SmLINC101519-IBu is part of the brown module in males and the black module in females, both significantly associated with B. moojeni venom incubation, while SmLINC156349-IBu is part of the green module in males, which is significantly associated with incubation with both B. moojeni and B. jararacussu venoms. This highlights that these lncRNAs are possibly involved in the molecular changes induced by the venoms and indicates that the exposure to venoms, especially in males, modulated pathways containing lncRNAs previously known to be essential for S. mansoni homeostasis and reproduction.
In this study, WGCNA pointed to lncRNAs that act as hubs in modules significantly associated with venom incubation, especially in male worms. These lncRNA hubs are likely to be involved in the molecular pathways affected by incubation with the venoms, possibly regulating transcriptionally or post-transcriptionally the expression of the other genes detected in the modules, including protein-coding genes. Validation by RT-qPCR showed that six out of the seven selected lncRNAs are significantly DE in S. mansoni male samples incubated with B. moojeni or B. jararacussu venoms. Therefore, this validation reinforces the potential of some of these selected lncRNAs as new candidates for further functional assays involving their knockdown or overexpression.
Among the selected lncRNAs, SmLNCA123831-IBu appears as one of the strongest candidates for further studies. This lncRNA is one of the most highly expressed transcripts in male S. mansoni out of the seven lncRNAs selected for validation, with an average TPM of 28.48 (Supplementary Figure S3) [59]. SmLNCA123831-IBu was downregulated in male samples incubated with both B. jararacussu and B. moojeni venoms, and this result was validated by RT-qPCR after incubation with both venoms. Meanwhile, this lncRNA is also downregulated in S. mansoni adult worm couples obtained from mice after treatment with a sub-lethal dose of PZQ at both four and seven weeks post-infection [41] and in females treated in vitro with 5-AzaC [42]. In the context of this study, SmLNCA123831-IBu is a hub of the turquoise module, significantly associated with incubation with both B. jararacussu and B. moojeni venoms in males. Together, these results suggest that SmLNCA123831-IBu may have a role in pathways downregulated in the parasite under stressful conditions, which are common among exposure to PZQ, to 5-AzaC and to the studied Bothrops venoms.
Furthermore, SmLNCA123831-IBu is an antisense lncRNA that overlaps the protein-coding gene Smp_012380.1 (putative voltage-gated potassium channel, subunit β) at the genomic opposite strand. Antisense lncRNAs in eukaryotes can exert diverse biological and cellular roles by positively or negatively regulating the expression of nearby genes either in cis or in trans [60,61,62]. Thus, SmLNCA123831-IBu may act as a regulator of Smp_012380.1 expression. This protein-coding gene is annotated as a putative subunit β of a voltage-gated potassium channel and is part of the WGCNA purple module in males. This module is significantly associated with incubation with B. moojeni venom and shows 25 enriched cellular component GO terms, including cell body, main axon, neuronal cell body, peptidase complex and proteasome complex (Figure 6). Meanwhile, the turquoise module in males, which contains SmLNCA123831-IBu, has one enriched GO term related to postsynaptic membrane. Interestingly, turquoise and purple modules are highly negatively correlated in the WGCNA (Supplementary Figure S4) and show enriched GO terms related to neural information transmission. Additionally, single-cell data (Supplementary Figure S5) point to SmLNCA123831-IBu enrichment in cell clusters of tegumental development (meg1+ and egc1+) in males [63,64]. Tegumental membrane potential in adult male S. mansoni is known to be primarily dependent on the potassium gradient across the surface [65]. Therefore, we suggest that SmLNCA123831-IBu may interfere with potassium channel expression during worm tegumental development, being critical for parasite surface integrity and, therefore, for survival in human hosts. Considering its upregulation in PZQ, 5-AzaC and Bothrops venom exposures, SmLNCA123831-IBu shows up as a strong candidate for further functional studies and assays, such as in vitro and in vivo knockdown.
Other promising candidates pointed out by this study are SmLINC150454-IBu and SmLINC121220-IBu. In the RNA-Seq, SmLINC150454-IBu is upregulated in males incubated with B. moojeni venom and was validated by RT-qPCR. This lncRNA is also upregulated in adult worm couples obtained from mice treated with PZQ at seven weeks post-infection [41] and in females treated in vitro with 5-AzaC [42]. SmLINC150454-IBu has higher expression in S. mansoni schistosomula (Supplementary Figure S3) [59], although it shows high expression in male samples, with an average TPM of 24.52. This lncRNA also shows ubiquitous expression in single-cell expression data (Supplementary Figure S5) [63]. In humans, ubiquitously expressed lncRNAs were identified to serve universal housekeeping functions, being required for the maintenance of basal cellular functions [66]. Therefore, the ubiquitous and high expression of SmLINC150454-IBu in males, together with its upregulation after Bothrops venoms, PZQ and 5-AzaC treatment contexts, suggests a putative role of SmLINC150454-IBu in gene expression modulation of male S. mansoni under stressful contexts and highlights this lncRNA as a promising candidate for further investigations.
Notably, in the RNA-Seq, SmLINC121220-IBu was upregulated in male samples incubated with B. moojeni venom and was also validated by RT-qPCR. Despite not showing a high expression in male S. mansoni (TPM average of 4.8) (Supplementary Figure S3), SmLINC121220-IBu shows a considerable expression throughout several cell clusters in single-cell RNA-Seq data (Supplementary Figure S5), which could indicate a role in basal cellular functions [66]. In the present study, SmLINC121220-IBu is a hub in the turquoise module in males, and its expression is significantly correlated with protein-coding genes related to GO terms enrichment in the post-synaptic membrane (Figure 7). These results suggest a putative role of SmLINC121220-IBu in gene expression modulation upon B. moojeni venom incubation in male S. mansoni, possibly related to nervous information transmission across the parasite, making it worth further in-depth analyses. It is important to note that GO annotations in the genome of S. mansoni are less complete than in model organisms, which may have limited the identification of additional pathways affected by venom incubation in this study.
Altogether, these findings indicate that Bothrops snake venoms, especially B. moojeni, affect key biochemical pathways essential for parasite survival and therefore exhibit a strong potential for the development of pharmacologically active molecules against S. mansoni. This effectiveness stems from the biochemical complexity of snake venoms, which typically induce systemic shock and profound molecular disruptions in prey, comprising a multi-target mechanism that appears to be mirrored in the significant alterations observed in the treated parasites. Phenotypical and molecular results of this study highlight the importance of future studies testing venom fractions and investigating their pharmacologically active molecules against S. mansoni. Meanwhile, WGCNA showed that lncRNAs are not only modulated by B. moojeni or B. jararacussu venom incubation in male samples but are also hubs of modules significantly associated with treatment, i.e., they may play a role in gene expression modulation by venoms. Three out of the seven lncRNA hubs evaluated here (SmLNCA123831-IBu, SmLINC150454-IBu and SmLINC121220-IBu) are proposed as particularly promising candidates for further functional assays, including in vitro and in vivo silencing and whole-mount in situ hybridization [39,63]. Overall, this study presents the first results of large-scale molecular changes in S. mansoni adult worms following snake venom incubations and points to new S. mansoni lncRNAs that should be prioritized in future functional studies.

4. Materials and Methods

4.1. Parasite Material

The BH (Belo Horizonte) strain of S. mansoni is maintained in the intermediate host, the snail Biomphalaria glabrata, and in the definitive host, golden hamsters (Mesocricetus auratus). For the recovery of adult worms, 3–4-week-old hamsters were infected by exposure to a suspension containing approximately 200–250 S. mansoni cercariae [67]. After 49 days, adult S. mansoni worms were recovered by portal hepatic perfusion. The recovered adult parasites were maintained in BME medium (Vitrocell, Campinas, SP, Brazil) supplemented with 10% fetal bovine serum (Vitrocell, Campinas, SP, Brazil), 2% penicillin/streptomycin, and 0.5% gentamicin (Vitrocell, Campinas, SP, Brazil) at 37 °C and 5% CO2.

4.2. Parasite Incubation with Venoms

Adult S. mansoni worm couples were incubated with each Bothrops venom at a concentration of 25 µg/mL (sublethal dose) for 24 h in 12-well plates, with each well containing 2 mL of supplemented BME medium and 5 couples. Four biological replicates were performed, and 10–15 worm couples were used in each condition for each biological replicate. The venoms tested were obtained from the snakes B. atrox, B. brazili, B. cotiara, B. jararaca, B. jararacussu, B. leucurus, B. moojeni, and B. neuwiedi. The venoms were supplied in lyophilized form by the Strategic Center for Venoms and Antivenoms (NEVAS, Butantan Institute, São Paulo, Brazil). Each venom sample consisted of a pooled venom extracted from animals from different regions of Brazil. The samples were diluted in sterile PBS to a concentration of 1 mg/mL. Protein concentrations of each venom were determined using the BCA reagent (BCA Protein Assay Kit, Thermo Fisher Scientific, Waltham, MA, USA), with bovine serum albumin as a standard (Sigma-Aldrich, St. Louis, MO, USA). The samples were then aliquoted and stored at –80 °C until use. As a positive control, adult worms were incubated with PZQ at a concentration of 1.5 µg/mL. After incubation, worms were collected, washed in PBS, and stored in RNAlater (Thermo Fisher Scientific, Waltham, MA, USA) for RNA extraction.

4.3. Parasite Viability Evaluation

Using a light microscope (Olympus CKX41, Münster, Germany), adult worms were evaluated according to three parameters: pairing, attachment to the plate, and motility. To assess motility, the criteria described by Horiuchi et al. [68] were followed, in which three motility scores were established: score 3 (full-body movement), score 1.5 (partial movement or live but immobile worms), and score 0 (worms considered dead). For percentage calculation, the motility index (MI) was determined as M I = n N n / N n , where Nn represents the number of worms with score n. Relative motility (RM) was calculated as ( M I s a m p l e / M I c o n t r o l ) × 100 . Adult worm viability was determined by measuring ATP levels using the CellTiter-Glo kit (Promega, Madison, WI, USA), according to the manufacturer’s recommendations and as previously performed by our group [39,69]. In this assay, the CTG reagent, which generates a luminescent signal, was added to the previously treated and freshly lysed adult parasites, and luminescence was measured 15 min after reagent addition. The luminescence-based viability assay determines the amount of ATP present in the parasites, indicating the presence of cells with higher or lower metabolic activity. PBS was used as a negative control. The medium in which parasites were cultured was collected for egg counting. After medium collection, wells were washed with PBS to ensure complete collection of eggs. The medium was briefly centrifuged for egg deposition, the volume was adjusted to 1000 μL and 100 μL aliquots were taken for egg counting under a bright light with 4× magnification using an Olympus CKX41 inverted microscope (Münster, Germany). Counting was performed after in vitro incubation with venoms (or controls) for 24 h, and the number of eggs/couple/day of incubation was then estimated.

4.4. RNA Extraction and cDNA Synthesis

After adult worms’ collection and storage, worm couples were manually separated using tweezers and a stereomicroscope (Motic, Carlsbad, CA, USA), while maintaining parasites in a plate containing RNAlater (Thermo Fisher Scientific, Waltham, MA, USA). RNA extraction was performed separately for females and males. Total RNA extraction from the parasites was carried out using the RNeasy Micro kit (Qiagen, Hilden, Germany) in three biological replicates, according to the manufacturer’s instructions and as routinely performed by our group [39,41,42]. RNA purity was assessed by measuring RNA sample absorbance at 260, 280, and 230 nm. RNA integrity was verified by capillary electrophoresis using the 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA) with the Agilent RNA 6000 Pico kit protocol. RNA concentration was determined using the Qubit 2.0 Fluorometer (Invitrogen, Waltham, MA, USA) and a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). RNA was extracted from control adult worms (incubated with PBS) and from worms incubated with B. jararacussu or B. moojeni venoms at a concentration of 25 µg/mL for 24 h, in three biological replicates. Synthesis of cDNA for RT-qPCR was performed using 200 ng of each adult worm sample and Superscript IV Kit (Thermo Fisher Scientific, Waltham, MA, USA), following the manufacturer’s instructions [39,41,42].

4.5. RNA-Seq

RNA-Seq was performed with samples from male and female worms (three biological replicates each) incubated with B. jararacussu or B. moojeni venom or samples incubated with PBS (negative controls). Strand-specific cDNA libraries were constructed from the extracted RNA samples. Library preparation was carried out by BGI Genomics (Shenzhen, China) using the “Strand-Specific Transcriptome Library Construction” protocol (DNBSEQ, SOP-SS-115), and library concentration and quality were assessed using the 2100 Bioanalyzer (Agilent). Libraries were pooled and sequenced (300 cycles, paired-end reads) on a DNBSEQ-G400 instrument (MGI Tech, Shenzhen, China). Sequencing data were deposited at the NCBI Sequence Read Archive (SRA) under the BioProject accession number PRJNA1442209.
RNA-Seq analyses to identify statistically significant differentially expressed genes (DEGs) were conducted following previously established and published protocols from our group [39,70]. In brief, read quality was assessed using FASTQC (v0.11.7), and adapter trimming and removal of low-quality reads were performed using FASTP (v0.20.0) [71]. RNA-Seq reads were mapped against the Schistosoma mansoni genome PRJEA36577 (v7), retrieved from WormBase (schistosoma_mansoni.PRJEA36577.WBPS14.genomic_softmasked.fa) with a transcriptome annotation previously published by our research group [34]. This transcriptome comprises 10,520 protein-coding genes and 16,583 lncRNAs annotated in version 7 of the S. mansoni genome (v7). Alignment was performed using the STAR algorithm (v2.7.0c) [72] with default parameters, modifying only the maximum number of multiple alignments per read (20×) and the maximum mismatch rate relative to read length (set to 0.3). Read counting was conducted using RSEM (v1.3.1) [73] with the same transcriptome previously published by our group [34]. Statistical analysis to identify DEGs was performed by comparing each venom-treated group with the control group using two distinct algorithms: (i) limma (v3.48.3) + voom (v3.48.3) [74] and (ii) edgeR (v3.34.1) + svaseq (v 3.40.0) [75,76]. Only genes identified as differentially expressed (DE) in both analyses were reported. DEGs are presented in an unsupervised hierarchical clustering analysis constructed using the pheatmap function (v1.0.12) in the R platform (v4.1.0) [77].

4.6. Weighted Gene Co-Expression Network Analysis

Weighted Gene Co-Expression Network Analysis (WGCNA, v1.70-3) aims to evaluate gene expression patterns to construct co-expression modules [78,79]. To build these modules, it is necessary to assume a scale-free topology, as described in Network Medicine [80], in which many genes have few connections while a few genes, referred to as network hubs, have many connections. To construct a scale-free network, the algorithm uses a soft-thresholding power (β), which is selected to maximize scale-free network properties. Thus, the adjacency matrix containing gene–gene correlations was raised to the selected power until scale-free topology was achieved (Supplementary Figure S6). For network construction, the selected power was 14 for females and 7 for male samples (Supplementary Figure S6). After this step, a Topological Overlap Matrix (TOM) was calculated, and distances were derived from the corresponding dissimilarity matrix. Genes with low dissimilarity distance were then grouped into the same module (Supplementary Figure S7). All networks were constructed as “unsigned,” meaning that both positive and negative correlations were considered in building the co-expression network. Herein, the analysis was performed using RNA-Seq data to guide the selection of central (hub) lncRNA genes for further validation by RT-qPCR, focusing on those showing altered expression in adult worms following incubation with Bothrops venoms. The analysis was conducted separately for S. mansoni males and females incubated with B. jararacussu or B. moojeni venoms and their respective negative controls.
A total of nine samples per sex were analyzed, comprising: three samples of females and three samples of males incubated with B. jararacussu venom, three samples of females and three samples of males incubated with B. moojeni venom, and three control female and three control male samples. In the first step, transcripts with a median expression equal to zero were filtered out. Next, genes were normalized using the variance stabilizing transformation (VST), and the coefficient of variation (CV) was calculated. The 1% of genes with the lowest CV were removed, resulting in 18,028 transcripts for females and 17,999 transcripts for males. Genes with low variation across samples tend to be less meaningful in biological contexts, and filtering them reduces noise. At this stage, one control female sample was excluded due to an outlier clustering pattern. After module identification, module preservation analysis was performed in both datasets with 100 permutation rounds and varying sample sizes (5 to 9) to test the robustness of each module; all of them resulted in a score (Z-summary preservation) > 10, which reflects topological preservation even at the smaller sample sizes [81]. After verifying the robustness of each module, a linear model statistical analysis was performed in R [77] to determine which modules were significantly associated with venom treatment, using the group as a categorical independent variable. The response variable consisted of the eigengenes of each module, which summarize the overall expression pattern of the genes within each module. Additionally, a χ2 test was performed to assess whether there was an association between modules and DEGs. Only results with a p-value ≤ 0.05 and in which the observed number of genes exceeded the expected number were considered significant.
To determine whether modules were associated with specific biological functions, enrichment analysis was conducted using clusterProfiler (v4.0.5) [82] in R (v4.1.0) [77]. First, genes were annotated using the eggNOG 5.0 (v 5.0.2) database [83], and enrichment analysis was then performed with clusterProfiler (v4.0.5) across the three Gene Ontology (GO) categories BP, CC and MF [84]. Only categories with FDR ≤ 10% were considered significantly enriched. Furthermore, hub genes within each module were identified.

4.7. Target Gene Selection for Validation by RT-qPCR

We selected lncRNAs considered as hub genes belonging to modules significantly correlated with one or both Bothrops venoms incubations in male and female worms separately, and that were DE in the male RNA-Seq results (FDR ≤ 5%). Among these, we selected lncRNAs that had (i) TPM > 1, (ii) fold-change (FC) > 2 in the RNA-Seq, and (iii) primer pairs designed between two exons. All selected lncRNAs also had evidence of expression in other S. mansoni life-cycle stages (Supplementary Figure S3) and were detected in single-cell RNA-Seq analysis (Supplementary Figure S5). As a control, SmLINC143821-IBu was selected as an lncRNA non-DE in the RNA-Seq analysis (Supplementary Figure S2).
Additionally, the five most stable non-DE protein-coding genes across all RNA-Seq data were chosen as candidate reference genes for the RT-qPCR assays, given the better suitability of condition-specific reference genes as normalizers over standard housekeeping genes [59,85]. NormFinder [86] and geNorm [87] software were employed, via the online tool RefFinder [88] (https://www.ciidirsinaloa.com.mx/RefFinder-master/, accessed on 2 February 2026), to determine the two most stable candidate reference genes, and Smp_136320.1 and Smp_336360.1 were used to normalize the Cycle threshold (Ct) values and relative expression. RefFinder results are shown in Supplementary Table S14.

4.8. Primer Design and Validation by RT-qPCR

All primer pairs for DE lncRNAs and candidate reference genes were designed using Primer3 (https://bioinfo.ut.ee, accessed on 10 October 2025) and between two exons of selected genes. The primers were designed following the parameters: maximum primer size of 25 nt, annealing temperature ranging from 57 °C to 63 °C, GC content between 30% and 60%, product size varying between 90 and 250 nt, and a maximum allowable length of a mononucleotide repeat set to three. All primers were purchased from Thermo Fisher. Primer’s efficiencies were tested through RT-qPCR using 5 µL of 1× LightCycler 480 SYBR Green I Master Mix (Roche Diagnostics, Basel, Switzerland), 800 nM of each primer and 2.5 µL of 2-fold serial diluted cDNA samples obtained from a pool of S. mansoni male and female samples on a LightCycler 480 System instrument (Roche Diagnostics). The primer sequences and efficiencies are shown in Supplementary Table S15. RT-qPCR was performed using cDNA samples of males (three biological replicates) incubated with B. jararacussu or B. moojeni venoms and negative controls. The RT-qPCR assays were performed using 5 µL of 1× LightCycler 480 SYBR Green I Master Mix (Roche Diagnostics, Basel, Switzerland) with 800 nM of each primer pair and 2.5 µL of samples on a LightCycler 480 System instrument (Roche Diagnostics). All primers were tested in technical triplicates for all samples, in addition to a no-template control (NTC). Raw Cts values are provided in Supplementary Table S16.

4.9. Statistical Analysis

For phenotypical results, one-way ANOVA with Dunnett’s post-hoc correction was performed. To calculate differential gene expression, the delta-Ct method was applied [89], considering the efficiency values of each primer pair. Normal distribution and homogeneity of variances were evaluated employing the Shapiro-Wilk and Levene tests, respectively. As all data passed these tests, differences in the RT-qPCR expression of the assessed genes between control and incubated samples were evaluated by one-tailed Student’s t-test assuming equal variances; of note, the RNA-Seq results, obtained with an experimental design identical to that used for the RT-qPCR sampling, indicated the expected direction of modulation of the target lncRNAs following venom incubation, justifying the use of a one-tailed test. Statistical analysis and graphical representation were performed with R 4.5.2 and GraphPad Prism 8.4.3.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms27115027/s1.

Author Contributions

Conceptualization, M.Z.-C., A.F.-C. and M.S.A.; methodology, M.Z.-C., A.F.-C., P.J.P., A.C.T. and M.S.A.; software, P.J.P. and A.C.T.; validation, M.Z.-C. and A.F.-C.; formal analysis, M.Z.-C., A.F.-C., P.J.P. and A.C.T.; investigation, M.Z.-C., A.F.-C., T.C.T.-B., P.J.P. and V.G.-O.; resources, A.F.A.C., S.M.T.S., S.V.-A. and M.S.A.; data curation, M.Z.-C., A.F.-C. and A.C.T.; writing—original draft preparation, M.Z.-C.; writing—review and editing, A.F.-C., S.V.-A. and M.S.A.; visualization, M.Z.-C., A.F.-C., P.J.P. and A.C.T.; supervision, M.S.A.; project administration, M.S.A.; funding acquisition, S.V.-A. and M.S.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (grant 409278/2023-8 to M.S.A.), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, grant 2018/23693-5 to S.V.-A.), and Fundação Butantan. M.Z.-C. received a fellowship from CNPq (147983/2025-8). A.F.-C., P.J.P. and V.G.-O. received fellowships from FAPESP (24/16545-0, 24/16644-9 and 23/13588-8, respectively). S.V.-A. received an established investigator fellowship award from CNPq (313781/2025-7).

Institutional Review Board Statement

The study was approved by the Animal Ethics Committee of the Butantan Institute (CEUAIB No. 8859090919, approval date 21 June 2021).

Informed Consent Statement

Not applicable.

Data Availability Statement

Sequencing data were deposited at the NCBI Sequence Read Archive (SRA) under the BioProject accession number PRJNA1442209. The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding author.

Acknowledgments

We acknowledge Patricia Aoki Miyasato and Eliana Nakano, Laboratorio de Parasitologia, Instituto Butantan, for maintaining the S. mansoni life cycle. We would like to thank Ana Paula Lopes Vidal for the administrative support.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
5-AzaC5-Azacytidine
BPBiological Process
CCCellular Component
CtCycle threshold
CVCoefficient of variation
DEDifferentially expressed
DEGsDifferentially expressed genes
FCFold change
FDRFalse discovery rate
GOGene Ontology
kMEModule eigengene-based connectivity
lncRNALong non-coding RNA
lincRNALong intergenic non-coding RNA
lncaRNALong antisense non-coding RNA
lncsRNALong sense non-coding RNA
MFMolecular Function
PZQPraziquantel
RNA-SeqRNA Sequencing
RSEMRNA-Seq by Expectation Maximization
SEMStandard error of the mean
STARSpliced Transcripts Alignment to a Reference
TPMTranscripts per million
TOMTopological Overlap Matrix
VSTVariance stabilizing transformation
WGCNAWeighted Gene Co-expression Network Analysis

References

  1. Li, Q.; Li, Y.L.; Guo, S.Y.; Li, S.Z.; Wang, Q.; Lin, W.N.; Zhang, L.J.; Li, S.Z.; Zhou, X.N.; Xu, J. Global trends of schistosomiasis burden from 1990 to 2021 across 204 countries and territories: Findings from GBD 2021 study. Acta Trop. 2025, 261, 107504. [Google Scholar] [CrossRef]
  2. WHO. Available online: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis (accessed on 11 August 2025).
  3. McManus, D.P.; Dunne, D.W.; Sacko, M.; Utzinger, J.; Vennervald, B.J.; Zhou, X.N. Schistosomiasis. Nat. Rev. Dis. Primers 2018, 4, 13. [Google Scholar] [CrossRef] [PubMed]
  4. Vale, N.; Gouveia, M.J.; Rinaldi, G.; Brindley, P.J.; Gartner, F.; Correia da Costa, J.M. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. Antimicrob. Agents Chemother. 2017, 61, e02582–02516. [Google Scholar] [CrossRef]
  5. Pica-Mattoccia, L.; Cioli, D. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int. J. Parasitol. 2004, 34, 527–533. [Google Scholar] [CrossRef] [PubMed]
  6. Xiao, S.-h.; Catto, B.A.; Webster, L.T., Jr. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J. Infect. Dis. 1985, 151, 1130–1137. [Google Scholar] [CrossRef] [PubMed]
  7. de Moraes, J. Natural products with antischistosomal activity. Future Med. Chem. 2015, 7, 801–820. [Google Scholar] [CrossRef]
  8. Fischer-Carvalho, A.; Taveira-Barbosa, T.C.; Verjovski-Almeida, S.; Haeberlein, S.; Sena Amaral, M. Antischistosomal Potential of Animal-Derived Natural Products and Compounds. Microorganisms 2025, 13, 397. [Google Scholar] [CrossRef]
  9. Mohamed Abd El-Aziz, T.; Garcia Soares, A.; Stockand, J.D. Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving. Toxins 2019, 11, 564. [Google Scholar] [CrossRef]
  10. Herzig, V.; Cristofori-Armstrong, B.; Israel, M.R.; Nixon, S.A.; Vetter, I.; King, G.F. Animal toxins—Nature’s evolutionary-refined toolkit for basic research and drug discovery. Biochem. Pharmacol. 2020, 181, 114096. [Google Scholar] [CrossRef]
  11. El-Asmar, M.F.; Swelam, N.; Abdel Aal, T.M.; Ghoneim, K.; Hodhod, S.S. Factor(s) in the venom of scorpions toxic to Schistosoma mansoni (intestinal belharzia) cercariae. Toxicon 1980, 18, 711–715. [Google Scholar] [CrossRef]
  12. Stabeli, R.G.; Amui, S.F.; Sant’Ana, C.D.; Pires, M.G.; Nomizo, A.; Monteiro, M.C.; Romao, P.R.T.; Guerra-Sa, R.; Vieira, C.A.; Giglio, J.R.; et al. Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: An example of function versatility of snake venom proteins. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2006, 142, 371–381. [Google Scholar] [CrossRef]
  13. de Moraes, J.; Nascimento, C.; Miura, L.M.; Leite, J.R.; Nakano, E.; Kawano, T. Evaluation of the in vitro activity of dermaseptin 01, a cationic antimicrobial peptide, against Schistosoma mansoni. Chem. Biodivers. 2011, 8, 548–558. [Google Scholar] [CrossRef] [PubMed]
  14. Hassan, E.A.; Abdel-Rahman, M.A.; Ibrahim, M.M.; Soliman, M.F. In vitro antischistosomal activity of venom from the Egyptian snake Cerastes cerastes. Rev. Soc. Bras. Med. Trop. 2016, 49, 752–757. [Google Scholar] [CrossRef]
  15. Mohamed, A.H.; Hassab El-Nabi, S.E.; Bayomi, A.E.; Abdelaal, A.A. Effect of bee venom or proplis on molecular and parasitological aspects of Schistosoma mansoni infected mice. J. Parasit. Dis. 2016, 40, 390–400. [Google Scholar] [CrossRef]
  16. Tonk, M.; Vilcinskas, A.; Grevelding, C.G.; Haeberlein, S. Anthelminthic Activity of Assassin Bug Venom against the Blood Fluke Schistosoma mansoni. Antibiotics 2020, 9, 664. [Google Scholar] [CrossRef] [PubMed]
  17. Kellershohn, J.; Thomas, L.; Hahnel, S.R.; Grunweller, A.; Hartmann, R.K.; Hardt, M.; Vilcinskas, A.; Grevelding, C.G.; Haeberlein, S. Insects in anthelminthics research: Lady beetle-derived harmonine affects survival, reproduction and stem cell proliferation of Schistosoma mansoni. PLoS Neglected Trop. Dis. 2019, 13, e0007240. [Google Scholar] [CrossRef]
  18. Mahdy, A.; Mostafa, O.M.; Aboueldahab, M.M.; Nigm, A.H. Antiparasitic activity of Cerastes cerastes venom on Schistosoma mansoni infected mice. Exp. Parasitol. 2025, 268, 108866. [Google Scholar] [CrossRef]
  19. Guerra-Duarte, C.; de Sousa, V.P.; de Oliveira-Sousa, G.; Gomes Mol, M.P. Use of snake antivenom in the Region of the Americas: A systematic review. Bull. World Health Organ. 2025, 103, 785–798. [Google Scholar] [CrossRef] [PubMed]
  20. Andrade-Silva, D.; Zelanis, A.; Kitano, E.S.; Junqueira-de-Azevedo, I.L.; Reis, M.S.; Lopes, A.S.; Serrano, S.M. Proteomic and Glycoproteomic Profilings Reveal That Post-translational Modifications of Toxins Contribute to Venom Phenotype in Snakes. J. Proteome Res. 2016, 15, 2658–2675. [Google Scholar] [CrossRef]
  21. Queiroz, G.P.; Pessoa, L.A.; Portaro, F.C.; Furtado, M.e.F.; Tambourgi, D.V. Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus. Toxicon 2008, 52, 842–851. [Google Scholar] [CrossRef]
  22. Senise, L.V.; Yamashita, K.M.; Santoro, M.L. Bothrops jararaca envenomation: Pathogenesis of hemostatic disturbances and intravascular hemolysis. Exp. Biol. Med. 2015, 240, 1528–1536. [Google Scholar] [CrossRef]
  23. Larreche, S.; Chippaux, J.P.; Chevillard, L.; Mathe, S.; Resiere, D.; Siguret, V.; Megarbane, B. Bleeding and Thrombosis: Insights into Pathophysiology of Bothrops Venom-Related Hemostasis Disorders. Int. J. Mol. Sci. 2021, 22, 9643. [Google Scholar] [CrossRef]
  24. Quinn, J.J.; Chang, H.Y. Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet. 2016, 17, 47–62. [Google Scholar] [CrossRef] [PubMed]
  25. Ransohoff, J.D.; Wei, Y.; Khavari, P.A. The functions and unique features of long intergenic non-coding RNA. Nat. Rev. Mol. Cell Biol. 2018, 19, 143–157. [Google Scholar] [CrossRef] [PubMed]
  26. Mattick, J.S.; Amaral, P.P.; Carninci, P.; Carpenter, S.; Chang, H.Y.; Chen, L.L.; Chen, R.; Dean, C.; Dinger, M.E.; Fitzgerald, K.A.; et al. Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 2023, 24, 430–447. [Google Scholar] [CrossRef]
  27. Mercer, T.R.; Munro, T.; Mattick, J.S. The potential of long noncoding RNA therapies. Trends Pharmacol. Sci. 2022, 43, 269–280. [Google Scholar] [CrossRef]
  28. Pang, J.; Lau, Y.M.A.; Mahbub, F.; Tilstra, G.; Kemble, A.; Jiang, M.Q.; Sun, Y.; Knaggs, K.L.M.; Wang, T.; Couture-Senecal, J.; et al. Human and mouse long noncoding RNAs reengineered for exogenous delivery reduce LPS-induced inflammation in human macrophages and mice. Sci. Signal. 2026, 19, eadx2924. [Google Scholar] [CrossRef]
  29. Statello, L.; Guo, C.-J.; Chen, L.-L.; Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 2021, 22, 96–118, Correction in Nat. Rev. Mol. Cell Biol. 2021, 22, 159. [Google Scholar] [CrossRef]
  30. Kopp, F.; Mendell, J.T. Functional classification and experimental dissection of long noncoding RNAs. Cell 2018, 172, 393–407. [Google Scholar] [CrossRef] [PubMed]
  31. Liu, K.; Gao, L.; Ma, X.; Huang, J.-J.; Chen, J.; Zeng, L.; Ashby, C.R., Jr.; Zou, C.; Chen, Z.-S. Long non-coding RNAs regulate drug resistance in cancer. Mol. Cancer 2020, 19, 54. [Google Scholar] [CrossRef]
  32. Smallegan, M.J.; Rinn, J.L. Linking long noncoding RNA to drug resistance. Proc. Natl. Acad. Sci. USA 2019, 116, 21963–21965. [Google Scholar]
  33. Oliveira, K.C.; Carvalho, M.L.; Maracaja-Coutinho, V.; Kitajima, J.P.; Verjovski-Almeida, S. Non-coding RNAs in schistosomes: An unexplored world. An. Acad. Bras. Cienc. 2011, 83, 673–694. [Google Scholar] [CrossRef]
  34. Maciel, L.F.; Morales-Vicente, D.A.; Silveira, G.O.; Ribeiro, R.O.; Olberg, G.G.O.; Pires, D.S.; Amaral, M.S.; Verjovski-Almeida, S. Weighted Gene Co-Expression Analyses Point to Long Non-Coding RNA Hub Genes at Different Schistosoma mansoni Life-Cycle Stages. Front. Genet. 2019, 10, 823. [Google Scholar] [CrossRef]
  35. Vasconcelos, E.J.R.; Mesel, V.C.; daSilva, L.F.; Pires, D.S.; Lavezzo, G.M.; Pereira, A.S.A.; Amaral, M.S.; Verjovski-Almeida, S. Atlas of Schistosoma mansoni long non-coding RNAs and their expression correlation to protein-coding genes. Database 2018, 2018, bay068. [Google Scholar] [CrossRef]
  36. Vasconcelos, E.J.R.; daSilva, L.F.; Pires, D.S.; Lavezzo, G.M.; Pereira, A.S.A.; Amaral, M.S.; Verjovski-Almeida, S. The Schistosoma mansoni genome encodes thousands of long non-coding RNAs predicted to be functional at different parasite life-cycle stages. Sci. Rep. 2017, 7, 10508. [Google Scholar] [CrossRef] [PubMed]
  37. Aredes-Rocha, F.; Chaparro, C.; Grunau, C.; Guerra-Sa, R. Comprehensive identification and co-expression analysis of long non-coding RNAs across eight timepoints of Schistosoma mansoni life cycle. Mem. Inst. Oswaldo Cruz 2026, 121, e250114. [Google Scholar] [CrossRef] [PubMed]
  38. Freire, C.F.; Souza-Lopes, T.; Amaral, M.S.; Tahira, A.C.; Verjovski-Almeida, S. Comprehensive Schistosoma mansoni Hierarchical Transcriptome Assembly Points to Novel lncRNAs Associated with Sexual Dimorphism. Noncoding RNA 2026, 12, 9. [Google Scholar] [CrossRef] [PubMed]
  39. Silveira, G.O.; Coelho, H.S.; Pereira, A.S.A.; Miyasato, P.A.; Santos, D.W.; Maciel, L.F.; Olberg, G.G.G.; Tahira, A.C.; Nakano, E.; Oliveira, M.L.S.; et al. Long non-coding RNAs are essential for Schistosoma mansoni pairing-dependent adult worm homeostasis and fertility. PLoS Pathog. 2023, 19, e1011369. [Google Scholar] [CrossRef]
  40. Silveira, G.O.; Coelho, H.S.; Amaral, M.S.; Verjovski-Almeida, S. Long non-coding RNAs as possible therapeutic targets in protozoa, and in Schistosoma and other helminths. Parasitol. Res. 2022, 121, 1091–1115. [Google Scholar] [CrossRef]
  41. Jardim Poli, P.; Fischer-Carvalho, A.; Tahira, A.C.; Chan, J.D.; Verjovski-Almeida, S.; Sena Amaral, M. Long Non-Coding RNA Levels Are Modulated in Schistosoma mansoni following In Vivo Praziquantel Exposure. Noncoding RNA 2024, 10, 27. [Google Scholar] [CrossRef]
  42. Amaral, M.S.; Maciel, L.F.; Silveira, G.O.; Olberg, G.G.O.; Leite, J.V.P.; Imamura, L.K.; Pereira, A.S.A.; Miyasato, P.A.; Nakano, E.; Verjovski-Almeida, S. Long non-coding RNA levels can be modulated by 5-azacytidine in Schistosoma mansoni. Sci. Rep. 2020, 10, 21565. [Google Scholar] [CrossRef]
  43. Teixeira, S.C.; Borges, B.C.; Oliveira, V.Q.; Carregosa, L.S.; Bastos, L.A.; Santos, I.A.; Jardim, A.C.G.; Melo, F.F.; Freitas, L.M.; Rodrigues, V.M.; et al. Insights into the antiviral activity of phospholipases A(2) (PLA(2)s) from snake venoms. Int. J. Biol. Macromol. 2020, 164, 616–625. [Google Scholar] [CrossRef]
  44. Prinholato da Silva, C.; Costa, T.R.; Paiva, R.M.A.; Cintra, A.C.O.; Menaldo, D.L.; Antunes, L.M.G.; Sampaio, S.V. Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: Evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines. J. Venom. Anim. Toxins Incl. Trop. Dis. 2015, 21, 44. [Google Scholar] [CrossRef]
  45. Oliveira, V.Q.; Ferreira, E.L.; Morais, L.P.; Garcia, L.A.; Sousa, G.O.; Almeida, M.P.O.; de Souza, G.; Junior, J.P.L.; Dos Santos, N.C.L.; de Oliveira, R.M.; et al. BthTX-II, an Asp49 PLA(2) from Bothrops jararacussu, Impairs Toxoplasma gondii Infection: In Vitro and Ex Vivo Approaches. Pharmaceuticals 2025, 18, 1260. [Google Scholar] [CrossRef] [PubMed]
  46. de Vasconcelos Azevedo, F.V.P.; Zoia, M.A.P.; Lopes, D.S.; Gimenes, S.N.; Vecchi, L.; Alves, P.T.; Rodrigues, R.S.; Silva, A.C.A.; Yoneyama, K.A.G.; Goulart, L.R.; et al. Antitumor and antimetastatic effects of PLA(2)-BthTX-II from Bothrops jararacussu venom on human breast cancer cells. Int. J. Biol. Macromol. 2019, 135, 261–273. [Google Scholar] [CrossRef]
  47. Sanderson, L.; Bartlett, A.; Whitfield, P.J. In vitro and in vivo studies on the bioactivity of a ginger (Zingiber officinale) extract towards adult schistosomes and their egg production. J. Helminthol. 2002, 76, 241–247. [Google Scholar] [CrossRef] [PubMed]
  48. Fernandes, F.d.S.; Rezende Junior, C.O.; Fernandes, T.S.; da Silveira, L.S.; Rezende, C.A.; De Almeida, M.V.; de Paula, R.G.; Rodrigues, V.; Da Silva Filho, A.A.; Couri, M.R. Anthelmintic effects of alkylated diamines and amino alcohols against Schistosoma mansoni. BioMed Res. Int. 2013, 2013, 783490. [Google Scholar] [CrossRef] [PubMed]
  49. De Melo, N.I.; Magalhaes, L.G.; De Carvalho, C.E.; Wakabayashi, K.A.; De P. Aguiar, G.; Ramos, R.C.; Mantovani, A.L.; Turatti, I.C.; Rodrigues, V.; Groppo, M. Schistosomicidal activity of the essential oil of Ageratum conyzoides L. (Asteraceae) against adult Schistosoma mansoni worms. Molecules 2011, 16, 762–773. [Google Scholar] [CrossRef]
  50. Mitsui, Y.; Miura, M.; Aoki, Y. In vitro effects of artesunate on the survival of worm pairs and egg production of Schistosoma mansoni. J. Helminthol. 2009, 83, 7–11. [Google Scholar] [CrossRef]
  51. Mitsui, Y.; Aoki, Y. In vitro effect of current antimalarial drugs on the survival of paired Schistosoma mansoni adult worms and their egg production. Trop. Med. Health 2010, 38, 69–73. [Google Scholar] [CrossRef][Green Version]
  52. de Moraes, J.; Almeida, A.A.; Brito, M.R.; Marques, T.H.; Lima, T.C.; de Sousa, D.P.; Nakano, E.; Mendonça, R.Z.; Freitas, R.M. Anthelmintic activity of the natural compound (+)-limonene epoxide against Schistosoma mansoni. Planta Medica 2013, 79, 253–258. [Google Scholar] [CrossRef]
  53. Caixeta, S.C.; Magalhães, L.G.; de Melo, N.I.; Wakabayashi, K.A.; De P. Aguiar, G.; De P. Aguiar, D.; Mantovani, A.L.; Alves, J.M.; Oliveira, P.F.; Tavares, D.C. Chemical composition and in vitro schistosomicidal activity of the essential oil of Plectranthus neochilus grown in Southeast Brazil. Chem. Biodivers. 2011, 8, 2149–2157. [Google Scholar] [CrossRef]
  54. Winkelmann, F.; Gesell Salazar, M.; Hentschker, C.; Michalik, S.; Macháček, T.; Scharf, C.; Reisinger, E.C.; Völker, U.; Sombetzki, M. Comparative proteome analysis of the tegument of male and female adult Schistosoma mansoni. Sci. Rep. 2022, 12, 7569. [Google Scholar] [CrossRef]
  55. Kadesch, P.; Quack, T.; Gerbig, S.; Grevelding, C.G.; Spengler, B. Tissue- and sex-specific lipidomic analysis of Schistosoma mansoni using high-resolution atmospheric pressure scanning microprobe matrix-assisted laser desorption/ionization mass spectrometry imaging. PLoS Neglected Trop. Dis. 2020, 14, e0008145. [Google Scholar] [CrossRef]
  56. Wuhrer, M.; Koeleman, C.A.; Fitzpatrick, J.M.; Hoffmann, K.F.; Deelder, A.M.; Hokke, C.H. Gender-specific expression of complex-type N-glycans in schistosomes. Glycobiology 2006, 16, 991–1006. [Google Scholar] [CrossRef]
  57. Picard, M.A.; Boissier, J.; Roquis, D.; Grunau, C.; Allienne, J.-F.; Duval, D.; Toulza, E.; Arancibia, N.; Caffrey, C.R.; Long, T. Sex-biased transcriptome of Schistosoma mansoni: Host-parasite interaction, genetic determinants and epigenetic regulators are associated with sexual differentiation. PLoS Neglected Trop. Dis. 2016, 10, e0004930. [Google Scholar] [CrossRef]
  58. Winkle, M.; El-Daly, S.M.; Fabbri, M.; Calin, G.A. Noncoding RNA therapeutics—Challenges and potential solutions. Nat. Rev. Drug Discov. 2021, 20, 629–651. [Google Scholar] [CrossRef] [PubMed]
  59. Silveira, G.O.; Amaral, M.S.; Coelho, H.S.; Maciel, L.F.; Pereira, A.S.; Olberg, G.G.; Miyasato, P.A.; Nakano, E.; Verjovski-Almeida, S. Assessment of reference genes at six different developmental stages of Schistosoma mansoni for quantitative RT-PCR. Sci. Rep. 2021, 11, 16816. [Google Scholar] [CrossRef] [PubMed]
  60. Jiang, B.; Yuan, Y.; Yi, T.; Dang, W. The Roles of Antisense Long Noncoding RNAs in Tumorigenesis and Development through Cis-Regulation of Neighbouring Genes. Biomolecules 2023, 13, 684. [Google Scholar] [CrossRef] [PubMed]
  61. Yao, R.-W.; Wang, Y.; Chen, L.-L. Cellular functions of long noncoding RNAs. Nat. Cell Biol. 2019, 21, 542–551. [Google Scholar] [CrossRef]
  62. Wahlestedt, C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat. Rev. Drug Discov. 2013, 12, 433–446, Correction in Nat. Rev. Drug Discov. 2014, 13, 79. https://doi.org/10.1038/nrd4203. [Google Scholar] [CrossRef]
  63. Morales-Vicente, D.A.; Zhao, L.; Silveira, G.O.; Tahira, A.C.; Amaral, M.S.; Collins, J.J.; Verjovski-Almeida, S. Single-cell RNA-seq analyses show that long non-coding RNAs are conspicuously expressed in Schistosoma mansoni gamete and tegument progenitor cell populations. Front. Genet. 2022, 13, 924877. [Google Scholar] [CrossRef]
  64. Wendt, G.; Zhao, L.; Chen, R.; Liu, C.; O’Donoghue, A.J.; Caffrey, C.R.; Reese, M.L.; Collins, J.J. A single-cell RNA-seq atlas of Schistosoma mansoni identifies a key regulator of blood feeding. Science 2020, 369, 1644–1649. [Google Scholar] [CrossRef] [PubMed]
  65. Fetterer, R.H.; Pax, R.A.; Bennett, J.L. Schistosoma mansoni: Characterization of the electrical potential from the tegument of adult males. Exp. Parasitol. 1980, 49, 353–365. [Google Scholar] [CrossRef]
  66. Jiang, C.; Li, Y.; Zhao, Z.; Lu, J.; Chen, H.; Ding, N.; Wang, G.; Xu, J.; Li, X. Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs. Oncotarget 2016, 7, 7120–7133. [Google Scholar] [CrossRef]
  67. Lewis, F.A.; Tucker, M.S. Schistosomiasis. Adv. Exp. Med. Biol. 2014, 766, 47–75. [Google Scholar] [CrossRef] [PubMed]
  68. Horiuchi, A.; Satou, T.; Akao, N.; Koike, K.; Fujita, K.; Nikaido, T. The effect of free and polyethylene glycol-liposome-entrapped albendazole on larval mobility and number in Toxocara canis infected mice. Vet. Parasitol. 2005, 129, 83–87. [Google Scholar] [CrossRef]
  69. Pereira, A.S.A.; Amaral, M.S.; Vasconcelos, E.J.R.; Pires, D.S.; Asif, H.; daSilva, L.F.; Morales-Vicente, D.A.; Carneiro, V.C.; Angeli, C.B.; Palmisano, G.; et al. Inhibition of histone methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism. PLoS Neglected Trop. Dis. 2018, 12, e0006873. [Google Scholar] [CrossRef] [PubMed]
  70. Amaral, M.S.; Santos, D.W.; Pereira, A.S.A.; Tahira, A.C.; Malvezzi, J.V.M.; Miyasato, P.A.; Freitas, R.P.; Kalil, J.; Tjon Kon Fat, E.M.; de Dood, C.J.; et al. Rhesus macaques self-curing from a schistosome infection can display complete immunity to challenge. Nat. Commun. 2021, 12, 6181. [Google Scholar] [CrossRef]
  71. Chen, S.; Zhou, Y.; Chen, Y.; Gu, J. fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 2018, 34, i884–i890. [Google Scholar] [CrossRef]
  72. Dobin, A.; Davis, C.A.; Schlesinger, F.; Drenkow, J.; Zaleski, C.; Jha, S.; Batut, P.; Chaisson, M.; Gingeras, T.R. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 2013, 29, 15–21. [Google Scholar] [CrossRef] [PubMed]
  73. Li, B.; Dewey, C.N. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011, 12, 323. [Google Scholar] [CrossRef] [PubMed]
  74. Liu, R.; Holik, A.Z.; Su, S.; Jansz, N.; Chen, K.; Leong, H.S.; Blewitt, M.E.; Asselin-Labat, M.L.; Smyth, G.K.; Ritchie, M.E. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res. 2015, 43, e97. [Google Scholar] [CrossRef] [PubMed]
  75. Robinson, M.D.; McCarthy, D.J.; Smyth, G.K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26, 139–140. [Google Scholar] [CrossRef]
  76. Leek, J.T. svaseq: Removing batch effects and other unwanted noise from sequencing data. Nucleic Acids Res. 2014, 42, e161. [Google Scholar] [CrossRef]
  77. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2013. [Google Scholar]
  78. Langfelder, P.; Horvath, S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst. Biol. 2007, 1, 54. [Google Scholar] [CrossRef]
  79. Langfelder, P.; Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinform. 2008, 9, 559. [Google Scholar] [CrossRef]
  80. Barabási, A.-L.; Gulbahce, N.; Loscalzo, J. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 2011, 12, 56–68. [Google Scholar] [CrossRef]
  81. Langfelder, P.; Luo, R.; Oldham, M.C.; Horvath, S. Is my network module preserved and reproducible? PLoS Comput. Biol. 2011, 7, e1001057. [Google Scholar] [CrossRef]
  82. Yu, G.; Wang, L.G.; Han, Y.; He, Q.Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 2012, 16, 284–287. [Google Scholar] [CrossRef]
  83. Huerta-Cepas, J.; Szklarczyk, D.; Heller, D.; Hernández-Plaza, A.; Forslund, S.K.; Cook, H.; Mende, D.R.; Letunic, I.; Rattei, T.; Jensen, L.J. eggNOG 5.0: A hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses. Nucleic Acids Res. 2019, 47, D309–D314. [Google Scholar] [CrossRef] [PubMed]
  84. Consortium, G.O. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004, 32, D258–D261. [Google Scholar] [CrossRef] [PubMed]
  85. Dos Santos, K.C.G.; Desgagné-Penix, I.; Germain, H. Custom selected reference genes outperform pre-defined reference genes in transcriptomic analysis. BMC Genom. 2020, 21, 35, Correction in BMC Genom. 2021, 22, 607. [Google Scholar] [CrossRef]
  86. Andersen, C.L.; Jensen, J.L.; Ørntoft, T.F. Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004, 64, 5245–5250. [Google Scholar] [CrossRef] [PubMed]
  87. Vandesompele, J.; De Preter, K.; Pattyn, F.; Poppe, B.; Van Roy, N.; De Paepe, A.; Speleman, F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3, research0034.1. [Google Scholar] [CrossRef]
  88. Xie, F.; Wang, J.; Zhang, B. RefFinder: A web-based tool for comprehensively analyzing and identifying reference genes. Funct. Integr. Genom. 2023, 23, 125. [Google Scholar] [CrossRef] [PubMed]
  89. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
Figure 1. Evaluation of adult Schistosoma mansoni viability following in vitro incubation with venoms from eight different snake species of the genus Bothrops. Adult worms were incubated for 24 h with each of the indicated venoms separately at a concentration of 25 µg/mL or with praziquantel (1.5 µg/mL) as a positive control. (A) Percentage of paired worm couples after incubation. (B) Percentage of worm couples attached to the plate after incubation. (C) Percentage reduction in worm motility levels relative to control worms. (D) Quantification of ATP levels. The mean of two technical replicates from each of four biological replicates per condition was used. (E) Number of eggs laid per worm pair over 24 h. Means ± SEM of three (AC) and four (D,E) biological replicates are shown. A one-way ANOVA with Dunnett’s post-hoc correction test was applied. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001, and (****) = p < 0.0001.
Figure 1. Evaluation of adult Schistosoma mansoni viability following in vitro incubation with venoms from eight different snake species of the genus Bothrops. Adult worms were incubated for 24 h with each of the indicated venoms separately at a concentration of 25 µg/mL or with praziquantel (1.5 µg/mL) as a positive control. (A) Percentage of paired worm couples after incubation. (B) Percentage of worm couples attached to the plate after incubation. (C) Percentage reduction in worm motility levels relative to control worms. (D) Quantification of ATP levels. The mean of two technical replicates from each of four biological replicates per condition was used. (E) Number of eggs laid per worm pair over 24 h. Means ± SEM of three (AC) and four (D,E) biological replicates are shown. A one-way ANOVA with Dunnett’s post-hoc correction test was applied. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001, and (****) = p < 0.0001.
Ijms 27 05027 g001
Figure 2. Heatmaps of differentially expressed (DE) transcripts in Schistosoma mansoni male samples incubated with a sublethal dose (25 µg/mL) of Bothrops jararacussu (A) or Bothrops moojeni (B) venom compared with their respective controls. Gene expression levels were measured by RNA-Seq and are shown as Z-scores, which are the number of standard deviations below (downregulated, light blue) or above (upregulated, red) the mean expression value among treated and control samples for each gene; Z-score color scale indicated on the right. Each gene is in a horizontal line; replicate samples are in the columns. TREAT = sample incubated with Bothrops venom. CTRL = negative control sample. Statistical significance: FDR ≤ 5%.
Figure 2. Heatmaps of differentially expressed (DE) transcripts in Schistosoma mansoni male samples incubated with a sublethal dose (25 µg/mL) of Bothrops jararacussu (A) or Bothrops moojeni (B) venom compared with their respective controls. Gene expression levels were measured by RNA-Seq and are shown as Z-scores, which are the number of standard deviations below (downregulated, light blue) or above (upregulated, red) the mean expression value among treated and control samples for each gene; Z-score color scale indicated on the right. Each gene is in a horizontal line; replicate samples are in the columns. TREAT = sample incubated with Bothrops venom. CTRL = negative control sample. Statistical significance: FDR ≤ 5%.
Ijms 27 05027 g002
Figure 3. Heatmaps of differentially expressed transcripts in Schistosoma mansoni female samples incubated with a sublethal dose (25 µg/mL) of Bothrops jararacussu (A) or Bothrops moojeni (B) venom compared with their respective controls. Gene expression levels were measured by RNA-Seq and are shown as Z-scores, which are the number of standard deviations below (downregulated, light blue) or above (upregulated, red) the mean expression value among treated and control samples for each gene; Z-score color scale indicated on the right. Each gene is in a horizontal line; replicate samples are in the columns. TREAT = sample incubated with Bothrops venom. CTRL = negative control sample. Statistical significance: FDR ≤ 10%.
Figure 3. Heatmaps of differentially expressed transcripts in Schistosoma mansoni female samples incubated with a sublethal dose (25 µg/mL) of Bothrops jararacussu (A) or Bothrops moojeni (B) venom compared with their respective controls. Gene expression levels were measured by RNA-Seq and are shown as Z-scores, which are the number of standard deviations below (downregulated, light blue) or above (upregulated, red) the mean expression value among treated and control samples for each gene; Z-score color scale indicated on the right. Each gene is in a horizontal line; replicate samples are in the columns. TREAT = sample incubated with Bothrops venom. CTRL = negative control sample. Statistical significance: FDR ≤ 10%.
Ijms 27 05027 g003
Figure 4. Venn Diagram showing the number of significantly differentially expressed genes (DEGs) in the intersections of data from male or female S. mansoni worms exposed separately to either B. moojeni or B. jararacussu venoms. (A) Red: number of DEGs found in S. mansoni males exposed to B. moojeni venom. (B) Blue: number of DEGs found in S. mansoni males exposed to B. jararacussu venom. (C) Fuchsia: number of DEGs found in S. mansoni females exposed to B. moojeni venom. (D) Cyan: number of DEGs found in S. mansoni females exposed to B. jararacussu venom. Not shown in the diagram are the following intersections: A ∩ D = 8 genes; B ∩ C = 13 genes. Diagram drawn with the online tool https://www.deepvenn.com/.
Figure 4. Venn Diagram showing the number of significantly differentially expressed genes (DEGs) in the intersections of data from male or female S. mansoni worms exposed separately to either B. moojeni or B. jararacussu venoms. (A) Red: number of DEGs found in S. mansoni males exposed to B. moojeni venom. (B) Blue: number of DEGs found in S. mansoni males exposed to B. jararacussu venom. (C) Fuchsia: number of DEGs found in S. mansoni females exposed to B. moojeni venom. (D) Cyan: number of DEGs found in S. mansoni females exposed to B. jararacussu venom. Not shown in the diagram are the following intersections: A ∩ D = 8 genes; B ∩ C = 13 genes. Diagram drawn with the online tool https://www.deepvenn.com/.
Ijms 27 05027 g004
Figure 5. Gene Ontology (GO) terms enrichment within the WGCNA modules from S. mansoni female samples. Modules are shown in the columns, and each row represents an enriched GO term (FDR ≤ 10%) in each of the three categories, namely Biological Process (BP), Cellular Component (CC), and Molecular Function (MF), as indicated on the gray column at right. The significance of enrichment is proportional to the size of the dots. Colors of the dots correspond to the color names of modules. The top five enriched GO terms per module are displayed.
Figure 5. Gene Ontology (GO) terms enrichment within the WGCNA modules from S. mansoni female samples. Modules are shown in the columns, and each row represents an enriched GO term (FDR ≤ 10%) in each of the three categories, namely Biological Process (BP), Cellular Component (CC), and Molecular Function (MF), as indicated on the gray column at right. The significance of enrichment is proportional to the size of the dots. Colors of the dots correspond to the color names of modules. The top five enriched GO terms per module are displayed.
Ijms 27 05027 g005
Figure 6. Gene Ontology GO terms enrichment within the WGCNA modules from S. mansoni male samples. Modules are shown in the columns, and each row represents an enriched GO term (FDR ≤ 10%), in each of the three categories, namely Biological Process (BP), Cellular Component (CC), and Molecular Function (MF), as indicated on the gray column at right. The significance of enrichment is proportional to the size of the dots. Colors of the dots correspond to the color names of modules. The top five enriched GO terms per module are displayed.
Figure 6. Gene Ontology GO terms enrichment within the WGCNA modules from S. mansoni male samples. Modules are shown in the columns, and each row represents an enriched GO term (FDR ≤ 10%), in each of the three categories, namely Biological Process (BP), Cellular Component (CC), and Molecular Function (MF), as indicated on the gray column at right. The significance of enrichment is proportional to the size of the dots. Colors of the dots correspond to the color names of modules. The top five enriched GO terms per module are displayed.
Ijms 27 05027 g006
Figure 7. Co-expression networks of modules Blue (A), Green (B) and Turquoise (C) identified by Weighted Gene Co-expression Network Analysis (WGCNA), highlighting long non-coding RNAs (lncRNAs) selected for validation by RT-qPCR. Only hub lncRNAs from each module were retained (kME > 90th percentile). To further reduce network complexity, edges were filtered to include only correlations above the 75th percentile. Connections involving the selected lncRNAs of interest were highlighted within each module. Darker nodes represent lncRNAs, lighter nodes represent protein-coding genes, and yellow nodes indicate enriched GO terms.
Figure 7. Co-expression networks of modules Blue (A), Green (B) and Turquoise (C) identified by Weighted Gene Co-expression Network Analysis (WGCNA), highlighting long non-coding RNAs (lncRNAs) selected for validation by RT-qPCR. Only hub lncRNAs from each module were retained (kME > 90th percentile). To further reduce network complexity, edges were filtered to include only correlations above the 75th percentile. Connections involving the selected lncRNAs of interest were highlighted within each module. Darker nodes represent lncRNAs, lighter nodes represent protein-coding genes, and yellow nodes indicate enriched GO terms.
Ijms 27 05027 g007
Figure 8. Expression level of selected lncRNAs in male S. mansoni samples incubated with B. jararacussu or B. moojeni venoms. For each selected lncRNA indicated at the top of the panel, the expression obtained by RNA-Seq (TPM, transcripts per million) (left three columns) or by RT-qPCR (right three columns) is shown for the control assay (left), for B. jararacussu exposure (middle) and for B. moojeni exposure (right). Relative gene expression by RT-qPCR was calculated using the delta Ct approach, considering each pair of primers’ efficiency and normalizing to the average of two selected reference genes (Smp_136320.1 and Smp_336360.1). Means ± SEM of three biological replicates were used. Numbers above the horizontal lines across the columns indicate the fold-changes (FCs), which were calculated by dividing the treatment gene expression value by the control gene expression value in both RNA-Seq and RT-qPCR results. Student’s t-test between the treated sample group and its respective control group was applied assuming equal variances. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001.
Figure 8. Expression level of selected lncRNAs in male S. mansoni samples incubated with B. jararacussu or B. moojeni venoms. For each selected lncRNA indicated at the top of the panel, the expression obtained by RNA-Seq (TPM, transcripts per million) (left three columns) or by RT-qPCR (right three columns) is shown for the control assay (left), for B. jararacussu exposure (middle) and for B. moojeni exposure (right). Relative gene expression by RT-qPCR was calculated using the delta Ct approach, considering each pair of primers’ efficiency and normalizing to the average of two selected reference genes (Smp_136320.1 and Smp_336360.1). Means ± SEM of three biological replicates were used. Numbers above the horizontal lines across the columns indicate the fold-changes (FCs), which were calculated by dividing the treatment gene expression value by the control gene expression value in both RNA-Seq and RT-qPCR results. Student’s t-test between the treated sample group and its respective control group was applied assuming equal variances. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001.
Ijms 27 05027 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zenga-Carrenho, M.; Fischer-Carvalho, A.; Taveira-Barbosa, T.C.; Jardim Poli, P.; Guimarães-Oliveira, V.; Alencar Chaves, A.F.; Serrano, S.M.T.; Tahira, A.C.; Verjovski-Almeida, S.; Sena Amaral, M. Long Non-Coding RNAs Identified as Hub Genes by Weighted Gene Co-Expression Network Analysis in Schistosoma mansoni Following Incubation with Bothrops Snake Venoms. Int. J. Mol. Sci. 2026, 27, 5027. https://doi.org/10.3390/ijms27115027

AMA Style

Zenga-Carrenho M, Fischer-Carvalho A, Taveira-Barbosa TC, Jardim Poli P, Guimarães-Oliveira V, Alencar Chaves AF, Serrano SMT, Tahira AC, Verjovski-Almeida S, Sena Amaral M. Long Non-Coding RNAs Identified as Hub Genes by Weighted Gene Co-Expression Network Analysis in Schistosoma mansoni Following Incubation with Bothrops Snake Venoms. International Journal of Molecular Sciences. 2026; 27(11):5027. https://doi.org/10.3390/ijms27115027

Chicago/Turabian Style

Zenga-Carrenho, Marina, Agatha Fischer-Carvalho, Tereza Cristina Taveira-Barbosa, Pedro Jardim Poli, Vilaça Guimarães-Oliveira, Alison Felipe Alencar Chaves, Solange M. T. Serrano, Ana Carolina Tahira, Sergio Verjovski-Almeida, and Murilo Sena Amaral. 2026. "Long Non-Coding RNAs Identified as Hub Genes by Weighted Gene Co-Expression Network Analysis in Schistosoma mansoni Following Incubation with Bothrops Snake Venoms" International Journal of Molecular Sciences 27, no. 11: 5027. https://doi.org/10.3390/ijms27115027

APA Style

Zenga-Carrenho, M., Fischer-Carvalho, A., Taveira-Barbosa, T. C., Jardim Poli, P., Guimarães-Oliveira, V., Alencar Chaves, A. F., Serrano, S. M. T., Tahira, A. C., Verjovski-Almeida, S., & Sena Amaral, M. (2026). Long Non-Coding RNAs Identified as Hub Genes by Weighted Gene Co-Expression Network Analysis in Schistosoma mansoni Following Incubation with Bothrops Snake Venoms. International Journal of Molecular Sciences, 27(11), 5027. https://doi.org/10.3390/ijms27115027

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop